Genomic insights into NDM-1-producing Pseudomonas aeruginosa: Current status in a Bulgarian tertiary hospital and on the Balkans
Acta Microbiologica et Immunologica Hungarica · 2024
DOI: 10.1556/030.2024.02309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, 2024. Verfasst von Tanya Strateva und 2 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Medical Microbiology "Corr. Mem. Prof. Ivan Mitov, MD, DMSc", Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, beta-Lactamases, Tertiary Care Centers, Microbial Sensitivity Tests. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
The present study aimed to explore the genomic characteristics of eight New Delhi metallo-β-lactamase-1 (NDM-1)-producing carbapenem-resistant Pseudomonas aeruginosa (CRPA) isolates from a Bulgarian tertiary hospital (2021–2023) in comparison to bla NDM-1 -positive strains originating from the Balkans. Antimicrobial susceptibility testing, phenotypic assays for carbapenemase activity, PCR screening, whole-genome sequencing (WGS), and phylogenomic analysis were performed. Seven of the CRPA isolates investigated (Minimum inhibitory concentration values of imipenem and meropenem >32 mg L −1 ) were also resistant to piperacillin-tazobactam, ceftazidime, ceftazidime-avibactam, cefepime, ceftolozane-tazobactam, amikacin, tobramycin, ciprofloxacin, and levofloxacin, but were susceptible to colistin (0.5–2 mg L −1 ) and cefiderocol (0.25–1 mg L −1 ). The P. aeruginosa Pae57 isolate (designated Pae57) remained susceptible to aminoglycosides as well. WGS uncovered the co-existence of bla NDM-1 and bla GES-1 . The isolates belonged to the ST654 high-risk clone, except for Pae57 (ST611). Alignment against reference sequences revealed the presence of a Tn 21 transposon harboring ble MBL – bla NDM-1 –IS Aba125 . It was similar to that found in the P. aeruginosa ST654 NDM1_1 strain (GCA_020404785.1) from Serbia. Phylogenomic analysis of our isolates indicated that seven of them (ST654) differed from each other in no more than 44 single-nucleotide polymorphisms (SNPs). Pae57 (ST611) was strikingly different (>21,700 SNPs) compared to all Balkan strains. In conclusion, to our knowledge this is the first report of bla NDM-1 -positive P. aeruginosa ST611 isolation, which indicates the transmission dynamics of this determinant between high-risk and potentially high-risk P. aeruginosa clones. Obtained results unveil the dissemination of clonally related NDM-1-producing P. aeruginosa strains in the monitored hospital for approximately a 2-year period.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Department of Medical Microbiology "Corr. Mem. Prof. Ivan Mitov, MD, DMSc", Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria.
- 2Department of Clinical Microbiology and Virology, University Hospital Lozenetz, Sofia, Bulgaria.
- 3Department of Genetics, Faculty of Biology, Sofia University "St. Kliment Ohridski", Sofia, Bulgaria.
- 4BioInfoTech Laboratory, Sofia Tech Park, Sofia, Bulgaria.
ORCID-Profile: Tanya Strateva
Zitieren
APA
Strateva, T., Keuleyan, E., & Peykov, S. (2024). Genomic insights into NDM-1-producing Pseudomonas aeruginosa: Current status in a Bulgarian tertiary hospital and on the Balkans. Acta Microbiologica et Immunologica Hungarica. https://doi.org/10.1556/030.2024.02309
Vancouver
Strateva T, Keuleyan E, Peykov S. Genomic insights into NDM-1-producing Pseudomonas aeruginosa: Current status in a Bulgarian tertiary hospital and on the Balkans. Acta Microbiologica et Immunologica Hungarica. 2024. doi:10.1556/030.2024.02309
BibTeX
@article{Strateva2024,
author = {Strateva, Tanya and Keuleyan, Emma and Peykov, Slavil},
title = {Genomic insights into NDM-1-producing Pseudomonas aeruginosa: Current status in a Bulgarian tertiary hospital and on the Balkans},
journal = {Acta Microbiologica et Immunologica Hungarica},
year = {2024},
doi = {10.1556/030.2024.02309}
}
EUVIMED